Clinical Drug Experience Knowledgebase

Epilepsies, Partial

Leukemia, Lymphocytic, Chronic, B-Cell

Lymphoma, Non-Hodgkin

Narcolepsy

Sleep Apnea, Obstructive

Sleep Wake Disorders

Alcohol Drinking (Phase 4)

Alcoholism (Phase 4)

Alzheimer Disease (Phase 3)

Amyloidosis (Phase 2)

Amyotrophic Lateral Sclerosis (Phase 3)

Anemia, Sickle Cell (Phase 2)

Anxiety Disorders (Phase 4)

Apnea (Phase 4)

Asthma (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Back Pain (Phase 3)

Binge-Eating Disorder (Phase 3)

Bipolar Disorder (Phase 4)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Brain Neoplasms (Phase 1)

Breakthrough Pain (Phase 4)

Breast Neoplasms (Phase 4)

Bulimia (Phase 3)

Cancer Pain (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Small Cell (Phase 2)

Central Nervous System Neoplasms (Phase 2)

Chronic Pain (Phase 3)

Cognition Disorders (Phase 2)

Cognitive Dysfunction (Phase 2)

Dementia (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetic Neuropathies (Phase 3)

Disease (Phase 4)

Disorders of Excessive Somnolence (Phase 4)

Dysthymic Disorder (Phase 4)

Endometrial Neoplasms (Phase 2)

Eosinophilic Esophagitis (Phase 3)

Esophagitis (Phase 3)

Fatigue (Phase 4)

Feeding and Eating Disorders (Phase 3)

Fibromyalgia (Phase 4)

Glioma (Phase 2)

Hodgkin Disease (Phase 2)

Hyperkinesis (Phase 3)

Immunoglobulin Light-chain Amyloidosis (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Promyelocytic, Acute (Phase 2)

Lewy Body Disease (Phase 4)

Liver Diseases (Phase 1)

Low Back Pain (Phase 3)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 1)

Mental Disorders (Phase 4)

Migraine Disorders (Phase 3)

Motor Neuron Disease (Phase 3)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Myofascial Pain Syndromes (Phase 4)

Narcolepsy (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Nervous System Neoplasms (Phase 2)

Neuralgia (Phase 3)

Osteoarthritis (Phase 3)

Osteoporosis (Phase 1)

Ovarian Neoplasms (Phase 2)

Overweight (Phase 3)

Parasomnias (Phase 3)

Parkinson Disease (Phase 3)

Phobia, Social (Phase 4)

Polycythemia (Phase 2)

Polycythemia Vera (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Psychotic Disorders (Phase 4)

Pulmonary Eosinophilia (Phase 3)

Renal Insufficiency (Phase 1)

Sarcoidosis (Phase 3)

Schizophrenia (Phase 4)

Sciatica (Phase 2)

Sclerosis (Phase 3)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Sleep Deprivation (Phase 2)

Sleep Disorders, Circadian Rhythm (Phase 3)

Sleepiness (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Sleep Wake Disorders (Phase 4)

Small Cell Lung Carcinoma (Phase 3)

Substance-Related Disorders (Phase 1)

Syndrome (Phase 3)

Thrombocythemia, Essential (Phase 2)

Thrombocytosis (Phase 2)

Wounds and Injuries (Phase 3)